RevoDx HLA B*57:01 qPCR Kit

Genetic testing for HLA-B*57:01 is performed to prevent hypersensitivity reactions against the HIV chemopharmaceutic agent abacavir. Around 8 % of people carry the HLA-B*57:01 allele (range: Japanese 0.1 %, South Africans 19.6 %). It can be assumed that 8 to 61 % of HIV patients who carry this allele and are treated with abacavir will develop a hypersensitivity to the drug within six weeks.

Intended Use

RevoDx HLA B*57:01 qPCR Kit is a real-time PCR test intended for the qualitative detection of HLA B*57:01 alleles.